Measles is costing the U.S. millions of dollars. The true losses can't be counted.

In early 2026, as the United States grapples with over 1,000 confirmed measles cases, researchers from Yale and Johns Hopkins universities project that declining vaccination rates could cost the nation $1.5 billion annually through medical care, public health responses, and lost productivity, with public health departments across states like Texas, South Carolina, and Washington already struggling to contain outbreaks amid reduced federal funding for vaccination programs. The economic burden extends beyond immediate medical expenses, with each additional case averaging $16,000 for contact tracing, medical treatment, and quarantine monitoring, as evidenced by Clark County, Washington's 2019 outbreak of 72 cases that resulted in over $1 million in productivity losses alone. Public health officials like Katherine Wells, head of Lubbock's health department in Texas, have faced difficult choices during outbreaks, requesting additional funds only to be denied by state authorities while pulling staff from other duties to respond to exposures at pediatricians' offices, restaurants, and day cares. The financial strain on healthcare systems is particularly acute in areas with large outbreaks, such as South Carolina, which is currently experiencing the country's largest single outbreak in more than a generation with at least 1,000 cases in Spartanburg County. Despite redirecting emergency funding and requesting additional resources from the Centers for Disease Control and Prevention, health departments remain stretched thin, with Dr. David Wohl at the University of North Carolina Chapel Hill describing how "so many people working on this... how stretched people are" as the outbreak spreads across state lines. The CDC has sent $8.5 million to seven areas experiencing measles outbreaks over the past year, but this represents only a fraction of the total economic burden, which includes $41.1 million annually for basic medical needs, $947 million for public health response efforts, and $510.4 million in lost productivity according to Yale researchers. Beyond the economic calculations, the human cost of measles resurgence cannot be overlooked, with more than 10% of those infected requiring hospitalization with dangerous complications including pneumonia and encephalitis. Some patients face lifelong consequences like seizures, blindness, and learning disabilities, while in the most tragic cases, measles can be fatal, as evidenced by the deaths of two young girls in Texas. Public health experts emphasize that while the economic consequences are significant, the human impact represents an incalculable burden on families and communities. Dr. Richard Pan, a pediatrician and former California legislator, notes that "People need to recognize that there's a tremendous cost to these outbreaks... That cost, by the way, is being borne by American families," highlighting how measles, once eliminated in the U.S. in 2000, now threatens public health systems nationwide as vaccination rates continue to decline in over two-thirds of counties.